The upregulation of SOX4 was identified as an independent prognostic marker for poor prognosis in AML, and our in vitro experiments demonstrate the growth-impairing effect of Sox4 suppression on H9M cells, which was independently confirmed by in vivo studies [46]. The gene discussed is SOX4; the disease is acute myeloid leukemia.